These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20438988)

  • 1. Product-related adverse events in hemodialysis patients: improving recognition and response.
    Patel PR; Kallen AJ; Budnitz DS
    Am J Kidney Dis; 2010 May; 55(5):972; author reply 973. PubMed ID: 20438988
    [No Abstract]   [Full Text] [Related]  

  • 2. Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008.
    McMahon AW; Pratt RG; Hammad TA; Kozlowski S; Zhou E; Lu S; Kulick CG; Mallick T; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):921-33. PubMed ID: 20661880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From crisis to opportunity: a perspective on the heparin crisis.
    Sasisekharan R; Shriver Z
    Thromb Haemost; 2009 Nov; 102(5):854-8. PubMed ID: 19888519
    [No Abstract]   [Full Text] [Related]  

  • 4. [How safe is our treatment with heparins? (interview by Maria Weiss)].
    Lindhoff-Last E
    MMW Fortschr Med; 2008 May; 150(22):7. PubMed ID: 18700259
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute allergic-type reactions among patients undergoing hemodialysis--multiple states, 2007-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(5):124-5. PubMed ID: 18256585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tainted heparin story: an update.
    Guerrini M; Shriver Z; Bisio A; Naggi A; Casu B; Sasisekharan R; Torri G
    Thromb Haemost; 2009 Nov; 102(5):907-11. PubMed ID: 19888527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contaminated heparin preparations, severe adverse events and the contact system.
    Ramacciotti E; Wahi R; Messmore HL
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):489-91. PubMed ID: 18815138
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug-induced fatal adverse effects in the United States from 1999 to 2004].
    He M; Guo QL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 33(11):1060-5. PubMed ID: 19060378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-focus on safety.
    Golembiewski J
    J Perianesth Nurs; 2008 Aug; 23(4):276-8. PubMed ID: 18657765
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemodialysis patients' deaths in the USA by contaminant suspected heparin originating from China.
    Nosé Y
    Artif Organs; 2008 Jun; 32(6):425-6. PubMed ID: 18522553
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypersensitivity reaction and Chinese heparin].
    Désormeaux A; Montpas N; Adam A
    Ann Pharm Fr; 2009 May; 67(3):169-72. PubMed ID: 19446665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update: adverse events following civilian smallpox vaccination--United States, 2003.
    Can Commun Dis Rep; 2003 Nov; 29(22):194-6. PubMed ID: 14650096
    [No Abstract]   [Full Text] [Related]  

  • 13. Contaminant in the recalled unfractionated heparin preparations: where is the problem?
    Hoppensteadt DA; Wahi R; Adiguzel C; Iqbal O; Ramacciotti E; Bick RL; Messmore HL; Bansal V; Fareed J
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):261-6. PubMed ID: 18565985
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse reactions to anticoagulants and to antiplatelet drugs recorded by the German spontaneous reporting system.
    Tiaden JD; Wenzel E; Berthold HK; Müller-Oerlinghausen B
    Semin Thromb Hemost; 2005; 31(4):371-80. PubMed ID: 16149013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smallpox Vaccine Adverse Events Monitoring and Response System for the first stage of the smallpox vaccination program.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Feb; 52(5):88-9, 99. PubMed ID: 12588007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electronic reporting of infections associated with hemodialysis.
    Klevens RM; Tokars JI; Andrus M
    Nephrol News Issues; 2005 Jun; 19(7):37-8, 43. PubMed ID: 16008022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Story of heparin recall: what India can do?
    Harugeri A; Parthasarathi G; Ramesh M; Sharma J; Padmini Devi D
    J Postgrad Med; 2008; 54(3):222-4. PubMed ID: 18626174
    [No Abstract]   [Full Text] [Related]  

  • 18. Forensic pharmacovigilance and substandard or counterfeit drugs.
    Labadie J
    Int J Risk Saf Med; 2012; 24(1):37-9. PubMed ID: 22436258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing substitution errors involving high-concentration heparin products.
    Koczmara C; Cheng R; Hyland S
    Dynamics; 2008; 19(1):32-4. PubMed ID: 18416360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contaminated heparins].
    Monneret C
    Ann Pharm Fr; 2008 Aug; 66(4):212-5. PubMed ID: 18847567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.